Testosterone Increases Red Blood Cells – Diagnosis & Management

Testosterone therapy commonly raises red blood cell production, and most increases stay modest. The transcript explains that some men develop marked erythrocytosis with hemoglobin above twenty. It distinguishes routine lab drift from levels that approach secondary polycythemia. Thresholds for concern are framed using hematocrit and hemoglobin upper limits from typical reference ranges. A central point is that baseline high normal values predict a larger jump after androgen exposure. The discussion emphasizes that the risk is not theoretical when symptoms or extreme labs appear. It also notes that athletes using steroids often see even stronger red cell stimulation.

The case involves an overweight man with hypertension, hyperlipidemia, prediabetes, and atrial fibrillation. He is taking metformin, a blood pressure medicine, a statin, and rivaroxaban for anticoagulation. Before treatment, his hemoglobin and hematocrit are already near the upper end of normal. After starting testosterone cypionate around one hundred milligrams weekly, his hemoglobin exceeds twenty. His hematocrit climbs above sixty percent, which the transcript treats as an urgent abnormality. Phlebotomy lowers the values, and iron studies are reviewed alongside ferritin and saturation results. The narrative stresses that a hematologic workup should include hereditary hemochromatosis genes when appropriate.

Later evaluation finds significant obstructive sleep apnea that was not being treated. Genetic testing identifies a homozygous hereditary hemochromatosis mutation that may increase sensitivity. With these factors combined, the transcript argues that testosterone becomes the offending trigger for extreme labs. Management is described as stopping testosterone, performing phlebotomy, and addressing sleep apnea with CPAP. Future options include trying human chorionic gonadotropin to raise endogenous testosterone without large spikes. Another proposed approach is very small micro dosing to keep free testosterone near normal. Monitoring is framed around repeated CBC checks, vital signs, and cardiovascular screening when symptoms demand.